Polyarteritis Nodosa Workup
- Author: Dana Jacobs-Kosmin, MD; Chief Editor: Herbert S Diamond, MD more...
Imaging Studies
Angiography
Angiography should be considered if clinically involved tissue is inaccessible. Conventional angiography is preferred. Computed tomography angiography or magnetic resonance angiography are not as sensitive for smaller abnormalities but can reveal larger aneurysms and stenoses.[13]
Positive findings include aneurysms and stenoses of medium-sized vessels. (Note that these findings are not pathognomonic for PAN but rarely occur in MPA).[13]
Aneurysms are most commonly found in the kidney, liver, and mesenteric arteries, and their presence is associated with more severe and extensive disease.
Angiography has a higher yield in cases with evidence of intra-abdominal involvement, including clinical symptoms or signs and laboratory abnormalities of liver or renal function.
Electromyography (EMG) and nerve conduction studies (NCS) can be useful in revealing axonal nerve involvement and identifying asymmetry in nerve involvement. EMG/NCS can be used to guide a nerve biopsy, if necessary.[13, 24]
Other studies
Arteriograms reveal microaneurysms in the small- and medium-sized arteries of the kidneys and abdominal viscera.
Computed tomography (CT) scanning and magnetic resonance imaging (MRI) of the GI tract may show nonspecific abnormal findings, including bowel wall thickening, mesenteric vascular engorgement, ascites, bowel obstruction, or diffuse mucosal fold thickening. For PAN with CNS involvement, new techniques, including susceptibility for blood, diffusion, and perfusion-weighted images, make MRI a very powerful modality for differentiating intracranial hemorrhage from potentially reversible ischemia (since PAN lesions are typically irreversible and progressive).
Biopsy
When possible, a biopsy sample of involved, accessible tissue should be collected to aid in the diagnosis. The most accessible tissue sites for biopsy include the skin, sural nerve, testes, and skeletal muscle. The results of a retrospective study suggest muscle biopsy may be helpful for the diagnosis of systemic vasculitides, even in the absence of myalgias or creatine kinase level elevation.[26] Kidney biopsy carries a risk of aneurysmal rupture and bleeding.
Biopsies should be performed correctly to allow for adequate sampling of medium-sized arteries. Biopsy samples of skin nodules or ulcers should be collected at the edges and include deep dermis and subcutaneous fat.[5] In addition, nearby central ulcer areas, including subcutaneous tissue, should be included to increase diagnostic yield.[27]
Biopsy of small arteries from the abdominal viscera in conjunction with arteriography facilitates identification of the vasculitis.
Combined nerve and muscle biopsy is preferred. Biopsy of the sural nerve should be full-thickness to include epineural vessels.[24]
Histologic Findings
Histology reveals a focal necrotizing arteritis of generally mixed cellular infiltrate within the vessel wall. Nerve biopsy characteristically reveals axonal degeneration and fiber loss. Segmental demyelination may also be seen.[24]
When an inflammatory infiltrate is present around a vessel wall without necrotizing changes, features on nerve biopsy that strongly suggest angiopathic nerve injury include Wallerian degeneration and fiber loss in part of a fascicle, perineural necrosis, and neoangiogenesis around the epineurium or perineurium.[24] An occlusion of a muscular artery and leukocytic infiltrate is seen in the slide below.
Polyarteritis nodosa (PAN) is characterized by fibrinoid necrosis of the arterial wall with a leukocytic infiltrate. In this slide, a large, pale occlusion of a muscular artery can be seen. Within this collagenous tissue is a leukocytic infiltrate, which is the hallmark of PAN. Courtesy of Urbana Atlas of Pathology. Approach Considerations
Evidence of peripheral neuropathy should be sought carefully with history and electromyography (EMG), since it is a common complication of polyarteritis nodosa (PAN), being found in as many as 60% of patients. Mononeuritis multiplex is the most common form of PAN neuropathy, but other forms can be present.
Many neurologic and systemic disorders can present with headache. Pathologic headaches are often difficult to differentiate from benign headaches solely on clinical grounds. Severe, persistent headaches, with or without neurologic deficit, warrant complete neurologic evaluation, including brain-imaging studies.
Even though stroke is a late complication in many cases of PAN, it certainly can occur early. PAN and other vasculitic diseases should be considered in many patients with stroke with multiple foci or a combination of hemorrhage and infarction.
Electroencephalography (EEG) may show nonspecific findings of generalized slow wave activity during periods of encephalopathy or toxic delirium.
Laboratory studies
Laboratory findings in PAN are nonspecific but can help to establish the systemic nature of the disease. Findings include the following:
- Elevated erythrocyte sedimentation rate (ESR) and/or C-reactive protein - These markers may be useful in evaluating some patients for active disease but do not correlate with activity in all patients[5]
- Leukocytosis, normochromic anemia, or thrombocytosis
- Hepatitis B surface antigen and hepatitic C serologies
- Elevated creatinine level
- Mild proteinuria
- Elevated levels of liver enzymes
- Hypergammaglobulinemia - Found in 30% of patients with PAN
Cryoglobulins, circulating immune complexes, and decreased levels of serum complement (ie, C3, C4) may be observed in patients with HBV-related PAN but are otherwise uncharacteristic of idiopathic PAN.
Cerebrospinal fluid findings often are usually normal in PAN, but polymorphonuclear pleocytosis can be seen when meningeal signs are present.
ANCA testing is rarely positive in PAN. If ANCA testing is positive, the tests more commonly show a perinuclear (rather than cytoplasmic) pattern and antibodies to proteinase-3 and myeloperoxidase will be negative.[5] Antinuclear antibodies and rheumatoid factor are generally negative, but low positive titers may be detected.[5]
Kussmaul A, Maier R. Ueber eine bisher nicht beschriebene eigenthümliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskellähmung einhergeht. Dtsch Arch Klin Med. 1866;1:484-518.
Pettigrew HD, Teuber SS, Gershwin ME. Polyarteritis nodosa. Compr Ther. Fall 2007;33(3):144-9. [Medline].
Matteson EL. A history of early investigation in polyarteritis nodosa. Arthritis Care Res. Aug 1999;12(4):294-302. [Medline].
Davson J, Ball J, Platt R. The kidney in periarteritis nodosa. Q J Med. Jul 1948;17(67):175-202. [Medline].
Stone JH. Polyarteritis nodosa. JAMA. Oct 2 2002;288(13):1632-9. [Medline].
Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. Aug 1990;33(8):1088-93. [Medline].
Jennette JC, Falk RJ, Andrassy K. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. Feb 1994;37(2):187-92. [Medline].
Colmegna I, Maldonado-Cocco JA. Polyarteritis nodosa revisited. Curr Rheumatol Rep. Aug 2005;7(4):288-96. [Medline].
Jackson JM, Callen JP. Scarring alopecia and sclerodermatous changes of the scalp in a patient with hepatitis C infection. J Am Acad Dermatol. Nov 1998;39(5 Pt 2):824-6. [Medline].
Trepo C, Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun. May 2001;16(3):269-74. [Medline].
Mahr A, Guillevin L, Poissonnet M, Aymé S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum. Feb 15 2004;51(1):92-9. [Medline].
Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore). Sep 1995;74(5):238-53. [Medline].
Hughes LB, Bridges SL Jr. Polyarteritis nodosa and microscopic polyangiitis: etiologic and diagnostic considerations. Curr Rheumatol Rep. Feb 2002;4(1):75-82. [Medline].
Somer T, Finegold SM. Vasculitides associated with infections, immunization, and antimicrobial drugs. Clin Infect Dis. Apr 1995;20(4):1010-36. [Medline].
Soufir N, Descamps V, Crickx B. Hepatitis C virus infection in cutaneous polyarteritis nodosa: a retrospective study of 16 cases. Arch Dermatol. Aug 1999;135(8):1001-2. [Medline].
Watts RA, Mooney J, Lane SE, Scott DG. Rheumatoid vasculitis: becoming extinct?. Rheumatology (Oxford). Jul 2004;43(7):920-3. [Medline].
Hasler P, Kistler H, Gerber H. Vasculitides in hairy cell leukemia. Semin Arthritis Rheum. Oct 1995;25(2):134-42. [Medline].
McMahon BJ, Heyward WL, Templin DW, Clement D, Lanier AP. Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-term follow-up. Hepatology. Jan 1989;9(1):97-101. [Medline].
Selga D, Mohammad A, Sturfelt G, Segelmark M. Polyarteritis nodosa when applying the Chapel Hill nomenclature--a descriptive study on ten patients. Rheumatology (Oxford). Oct 2006;45(10):1276-81. [Medline].
Levine SM, Hellmann DB, Stone JH. Gastrointestinal involvement in polyarteritis nodosa (1986-2000): presentation and outcomes in 24 patients. Am J Med. Apr 1 2002;112(5):386-91. [Medline].
Saadoun D, Terrier B, Semoun O, Sene D, Maisonobe T, Musset L, et al. Hepatitis C virus-associated polyarteritis nodosa. Arthritis Care Res (Hoboken). Oct 27 2010;[Medline].
Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore). Jan 1996;75(1):17-28. [Medline].
Fernandes SR, Coimbra IB, Costallat LT. Uncommon features of polyarteritis nodosa: psychosis and angio-oedema. Clin Rheumatol. 1998;17(4):353-6. [Medline].
Griffin JW. Vasculitic neuropathies. Rheum Dis Clin North Am. Nov 2001;27(4):751-60, vi. [Medline].
Rosenberg MR, Parshley M, Gibson S, Wernick R. Central nervous system polyarteritis nodosa. West J Med. Nov 1990;153(5):553-6. [Medline]. [Full Text].
Hervier B, Durant C, Masseau A, Ponge T, Hamidou M, Mussini JM. Use of muscle biopsies for diagnosis of systemic vasculitides. J Rheumatol. Mar 2011;38(3):470-4. [Medline].
Ricotti C, Kowalczyk JP, Ghersi M, Nousari CH. The diagnostic yield of histopathologic sampling techniques in PAN-associated cutaneous ulcers. Arch Dermatol. Oct 2007;143(10):1334-6. [Medline].
Frohnert PP, Sheps SG. Long-term follow-up study of periarteritis nodosa. Am J Med. Jul 1967;43(1):8-14. [Medline].
Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum. Mar 2001;44(3):666-75. [Medline].
Berlit P. Diagnosis and treatment of cerebral vasculitis. Ther Adv Neurol Disord. Jan 2010;3(1):29-42. [Medline]. [Full Text].
Guillevin L, Mahr A, Cohen P, Larroche C, Queyrel V, Loustaud-Ratti V, et al. Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum. Jun 15 2004;51(3):482-7. [Medline].
Guillevin L, Lhote F, Leon A, Fauvelle F, Vivitski L, Trepo C. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients. J Rheumatol. Feb 1993;20(2):289-98. [Medline].
Guillevin L, Lhote F, Sauvaget F, Deblois P, Rossi F, Levallois D. Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis. May 1994;53(5):334-7. [Medline].
Erhardt A, Sagir A, Guillevin L, Neuen-Jacob E, Häussinger D. Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine. J Hepatol. Oct 2000;33(4):677-83. [Medline].
Wicki J, Olivieri J, Pizzolato G, Sarasin F, Guillevin L, Dayer JM. Successful treatment of polyarteritis nodosa related to hepatitis B virus with a combination of lamivudine and interferon alpha. Rheumatology (Oxford). Feb 1999;38(2):183-5. [Medline].
Molloy PJ, Friedlander L, Van Thiel DH. Combined interferon, famciclovir and GM-CSF treatment of HBV infection in an individual with periarteritis nodosa. Hepatogastroenterology. Jul-Aug 1999;46(28):2529-31. [Medline].

